scholarly journals The Difference of Potassium Level in Stage 5 Kidney Chronic Disease Patients Whose Using New and Re-use Hemodialyzer in RSD dr. Soebandi Jember

2019 ◽  
Vol 5 (3) ◽  
pp. 148
Author(s):  
Yuli Hermansyah ◽  
Dinda Ayu Wanodya Supriatiningsih ◽  
Bagus Hermansyah
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Replacement Therapy ◽  
Potassium Level ◽  
Good Condition ◽  
Total Sample ◽  
Kidney Replacement Therapy ◽  
Quasi Experimental ◽  
The Difference ◽  
The Cost

Stage 5 chronic kidney disease (CKD) is a condition where the renal function decrease, marked by the GFR value < 15/ml/minute/1,73 m2 with or without kidney damage history for 3 months or more that needs kidney replacement therapy, including hemodialysis. In Indonesia, hemodialysis was chosen for 82% from all the cases that needs kidney replacement therapy. However, the cost for hemodialysis therapy is considered as too expensive and burdens The National Health Insurance, Badan Penyelenggara Jaminan Sosial (BPJS), allowing the reuse of hemodialyzer as an alternative for cost-effectiveness. Re-use hemodialyzer is a term for using the same hemodialyzer for the same patient but on different therapy session. The main purpose of this research is to investigate the difference of Potassium level in stage 5 chronic kidney disease patients whose using new and re-use hemodialyzer in RSD dr. Soebandi Jember. This research used quasi experimental design by using blood sample that will be measured for the potassium level after using new hemodialyzer and re-use hemodialyzer for the 4th time in Hemodialysis Installation of RSD dr. Soebandi Jember on December 2018. Total sample of 19 patients chosen using inclusion and exclusion criteria. Collected data were analyzed using paired t-test. The result of statistical test shows that there is no significance potassium level difference in stage 5 chronic kidney disease whose using new and re-use hemodialyzer for the 4th time (p=0,094). The effectivity of hemodialyzer that still has a good condition and hemodialysis therapy that has been done in accordance with the procedure until the 4th reuse is the main factor of this result.   Keywords: CKD, potassium, re-use hemodialyzer

scholarly journals Effect of Topical Aromatherapy Turmeric Oil to Pruritus Scale on Chronic Kidney Disease Patients

2019 ◽  
Vol 6 (3) ◽  
pp. 396-400
Author(s):  
Rysida Ma’rifaul Khoirot ◽  
Kusnanto Kusnanto ◽  
Suprajitno Suprajitno
Keyword(s):  
Quality Of Life ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Social Impact ◽  
Total Sample ◽  
Uremic Pruritus ◽  
Number Of Patients ◽  
Quasi Experimental ◽  
And Control

Introduction : A large number of patients with chronic kidney disease suffer from uremic pruritus, which adversely affects the quality of life and comfort of patients with a potential psychological, functional and social impact, which results in increased morbidity. The purpose of this study was to determine the effect of the administration of turmeric essential oil aromatherapy which was applied topically pruritus, comfort and quality of life of CKD patients.Methods : This study used a quasi-experimental design with 2 groups (intervention and control), conducted in CKD patients receiving hemodialysis therapy. A total sample of 72 respondents with the division of each group of 36 people. The intervention was carried out independently by the patient for 2 weeks. Measurement using 5-D pruritus scale questionnaire.Results : This study showed a decrease in pruritus scale in 51 respondents (70.8%) after 2 weeks of therapy. Independent t statistical test obtained a significance value of 0.046 (p <0.05).Conclusion: Topical aromatherapy of turmeric oil affects pruritus scale on patients with chronic kidney disease who experience uremic pruritus.

scholarly journals A snapshot of European registries on Chronic Kidney Disease patients not on Kidney Replacement Therapy

2021 ◽  
Author(s):  
Kitty J Jager ◽  
Anders Åsberg ◽  
Frederic Collart ◽  
Cécile Couchoud ◽  
Marie Evans ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Replacement Therapy ◽  
Kidney Replacement Therapy

scholarly journals Sustainability of Chronic Kidney Disease Care

2021 ◽  
Vol 1 (7) ◽  
Author(s):  
Jonathan Harris ◽  
Charlene Argáez
Keyword(s):  
Chronic Kidney Disease ◽  
Renal Replacement Therapy ◽  
Kidney Disease ◽  
Health System ◽  
Replacement Therapy ◽  
Conservative Management ◽  
Home Dialysis ◽  
Home Based ◽  
Chronic Kidney Disease Care ◽  
The Cost

Strategies to contain the cost of chronic kidney disease (CKD) care and to improve patient outcomes were found across the continuum of care, from prevention and early disease management through later-stage interventions such as conservative management, dialysis, and transplantation. A variety of health system strategies, including funding reform, were identified to help support and enable sustainable CKD care. For those at risk of CKD or in early stages of the disease, public health interventions to support healthy behaviours and ensure access to primary health care seem crucial to preventing or delaying disease progression. For later-stage patients requiring renal replacement therapy, enhancing access to transplantation and home-based dialysis has the potential to reduce costs while improving outcomes and quality of life. Conservative management without dialysis is an option for those who may not be good candidates for renal replacement therapy or who wish to choose a less-invasive care option. From a health system policy perspective, funding reform may be warranted to enhance team-based CKD care with good continuity. Policy-makers should also consider the ways in which improving financial supports for caregivers, providing travel and expense reimbursement for home dialysis patients and living organ donors, and providing support for utility and ancillary costs of home dialysis could incentivize sustainable CKD care.

scholarly journals Comparison of Sodium Levels in Patients with Stage V Chronic Kidney Disease Whose Using New and Re-use Hemodialyzer in Hemodialysis Installation RSD dr. Soebandi Jember

2020 ◽  
Vol 6 (1) ◽  
pp. 19
Author(s):  
Yuli Hermansyah ◽  
Firda Novidyawati ◽  
Ayu Munawaroh Azis
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Sodium Level ◽  
Cross Sectional Study ◽  
Cross Sectional ◽  
Significant Difference ◽  
Kidney Replacement Therapy ◽  
The Cost ◽  
Hemodialysis Machine

Stage V Chronic Kidney Disease (CKD) is one of the most common medical case in the world. Stage V CKD defined as a condition where the renal function decrease progressively, marked by the GFR  <15/ml/minute/1,73 m2, with or without kidney damage history for three months. Patients diagnosed with Stage V CKD often needs kidney replacement therapy, one of which is hemodialysis. The cost needed for hemodialysis was considered as too expensive, forcing lots of medical staff in most countries using the method known as re-use hemodialyzer. Re-use hemodialyzer is a term for using the same hemodialyzer (or hemodialysis machine) for the same patient but on a different therapy session. The main purpose for this research is to investigate the sodium level in patients with Stage V CKD whose using new and re-use hemodialyzer in Hemodialysis Installation of RSD dr. Soebandi Jember. Analytic Observational Study is used for this research combined with Cross Sectional Study in December 2018. Total of 19 samples chosen with inclusion and exclusion criteria. Collected data is analyzed using paired t-test. The conclusion that can be obtained from this research is that there is no significant difference between sodium level in patients with Stage V CKD whose using new and re-use hemodialyzer (p=0,904). The effectivity and quality of the hemodialyzer is thought to be the main factor for this result. Keywords: Chronic Kidney Disease, sodium, re-use hemodialyzer

scholarly journals Chronic kidney disease in children in Ukraine

2021 ◽  
pp. 16-26
Author(s):  
S. P. Fomina
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Children And Adolescents ◽  
Replacement Therapy ◽  
Longitudinal Design ◽  
Pediatric Nephrology ◽  
Lower Probability ◽  
Cumulative Probability ◽  
First Choice ◽  
Kidney Replacement Therapy

The study aimed to summarize data of Chronic Kidney Disease (CKD) in children and adolescents in Ukraine. Methods. There were performed a qualitative study based on published documents and registers, and a cohort observational study included 3528 depersonalized patients with CKD diagnosed before the age of 18. That was used cross-sectional and longitudinal design for the structure, etiology, and outcomes analysis, period comparison (years 2014 and 2019), quantitative analyzes depending on patients age and nosology, risk measurements and survival function. Results. There was found the tendency to reduce the incidence of the genitourinary system diseases in childhood, and the predominance of these classes of diseases in adolescents. The main causes of CKD were congenital structural or histological abnormalities and glomerulonephritis. Prolonged kidney function preservation at the initial level was confirmed in many patients (CKD1 was maintained in 33.0% and CKD5 - in 56.6% causes after 5 years period) with the partial function improvement in CKD1-3. CKD1-4 probability at the 1st year of observation was 91.7±0.47%, at the 5th year - 84.2±0.82%. The structural CKD5 specialties in patients receiving Kidney Replacement Therapy have been established. There was a significantly higher risk of CKD5 during 5 years period after Acute Kidney Injury (OR 2.81-2.10), and a lower probability of CKD5 in patients with glomerulonephritis (OR 0.66-0.54) compared to other nosology. CKD pathomorphosis was found in the year 2019 compared to the year 2014: the kidney dysplasia as an etiological factor was increased (from 19.3% to 22.0%, р=0.040); the immediate outcome at the 1st year of observation was improved with the lower risk of declaring of Glomerular Filtration Rate (GFR) to CKD5 level (93.6% vs. 90.0%), but the late follow-up prognosis became worse (the cumulative probability of CKD1-4 at the 5th year of observation decreased from 85.5 to 73.9%, p=0.016); the structure of Kidney Replacement Therapy changed with the increasing part of transplanted patients (from 30.5% to 48.9%, p<0.001), especially as a first choice (pre-dialysis); the tendency to decrease the proportion of polycystic kidney disease in CKD and to increase it in CKD5 was revealed with risk raising of GFR loss <15 ml/min in the year 2019 compared to other nosology (OR 1.69, p=0.027). Conclusions. The established epidemiological and clinical realities are important for determining the kidney disease outcome in children and adolescents, assessing the medical management of these patients, sharpening the priorities of pediatric nephrology, and emphasizing the significance of further studies with appropriate regulations.

scholarly journals Self-management interventions for adults with chronic kidney disease: a scoping review

BMJ Open ◽  
2018 ◽  
Vol 8 (3) ◽  
pp. e019814 ◽  
Author(s):  
Maoliosa Donald ◽  
Bhavneet Kaur Kahlon ◽  
Heather Beanlands ◽  
Sharon Straus ◽  
Paul Ronksley ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Replacement Therapy ◽  
Scoping Review ◽  
Mixed Method ◽  
Self Management ◽  
Secondary Outcome ◽  
Management Interventions ◽  
Wide Range ◽  
Kidney Replacement Therapy

ObjectiveTo systematically identify and describe self-management interventions for adult patients with chronic kidney disease (CKD).SettingCommunity-based.ParticipantsAdults with CKD stages 1–5 (not requiring kidney replacement therapy).InterventionsSelf-management strategies for adults with CKD.Primary and secondary outcome measuresUsing a scoping review, electronic databases and grey literature were searched in October 2016 to identify self-management interventions for adults with CKD stages 1–5 (not requiring kidney replacement therapy). Randomised controlled trials (RCTs), non-RCTs, qualitative and mixed method studies were included and study selection and data extraction were independently performed by two reviewers. Outcomes included behaviours, cognitions, physiological measures, symptoms, health status and healthcare.ResultsFifty studies (19 RCTs, 7 quasi-experimental, 5 observational, 13 pre-post intervention, 1 mixed method and 5 qualitative) reporting 45 interventions were included. The most common intervention topic was diet/nutrition and interventions were regularly delivered face to face. Interventions were administered by a variety of providers, with nursing professionals the most common health professional group. Cognitions (ie, changes in general CKD knowledge, perceived self-management and motivation) were the most frequently reported outcome domain that showed improvement. Less than 1% of the interventions were co-developed with patients and 20% were based on a theory or framework.ConclusionsThere was a wide range of self-management interventions with considerable variability in outcomes for adults with CKD. Major gaps in the literature include lack of patient engagement in the design of the interventions, with the majority of interventions not applying a behavioural change theory to inform their development. This work highlights the need to involve patients to co-developed and evaluate a self-management intervention based on sound theories and clinical evidence.

scholarly journals Standardised Outcomes in Nephrology – Chronic Kidney Disease (SONG-CKD): a protocol for establishing a core outcome set for adults with chronic kidney disease who do not require kidney replacement therapy

Trials ◽  
2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Nicole Evangelidis ◽  
Benedicte Sautenet ◽  
Magdalena Madero ◽  
Allison Tong ◽  
Gloria Ashuntantang ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Replacement Therapy ◽  
Health Professionals ◽  
Core Outcome Set ◽  
Core Outcome ◽  
Outcome Set ◽  
Kidney Replacement Therapy ◽  
Randomised Controlled ◽  
Stakeholder Consensus

Abstract Background Globally, over 1.2 million people die from chronic kidney disease (CKD) every year. Patients with CKD are up to 10 times more likely to die prematurely than progress to kidney failure requiring kidney replacement therapy. The burden of symptoms and impaired quality of life in CKD may be compounded by comorbidities and treatment side effects. However, patient-important outcomes remain inconsistently and infrequently reported in trials in patients with CKD, which can limit evidence-informed decision-making. The Standardised Outcomes in Nephrology – Chronic Kidney Disease (SONG-CKD) aims to establish a consensus-based core outcome set for trials in patients with CKD not yet requiring kidney replacement therapy to ensure outcomes of relevance to patients, caregivers and health professionals are consistently reported in trials. Methods SONG-CKD involves four phases: a systematic review to identify outcomes (domains and measures) that have been reported in randomised controlled trials involving adults with CKD who do not require kidney replacement therapy; stakeholder key informant interviews with health professionals involved in the care of adults with CKD to ascertain their views on establishing core outcomes in CKD; an international two-round online Delphi survey with patients, caregivers, clinicians, researchers, policy makers and industry representatives to obtain consensus on critically important outcome domains; and stakeholder consensus workshops to review and finalise the set of core outcome domains for trials in CKD. Discussion Establishing a core outcome set to be reported in trials in patients with CKD will enhance the relevance, transparency and impact of research to improve the lives of people with CKD. Trial registration Not applicable. This study is registered with the Core Outcome Measures in Effectiveness Trials (COMET) database: http://www.comet-initiative.org/Studies/Details/1653.

Sign in / Sign up

Export Citation Format

Share Document